LOTTE Biologics Secures Major Commercial Manufacturing Agreement for Songdo Plant 1 Ahead of 2027 Launch
Trendline

LOTTE Biologics Secures Major Commercial Manufacturing Agreement for Songdo Plant 1 Ahead of 2027 Launch

What's Happening? LOTTE Biologics, co-led by James Park and Yoo-yeol Shin, has announced a significant commercial manufacturing agreement with a global pharmaceutical company. This agreement marks the first major commercial manufacturing commitment for LOTTE Biologics' Songdo Plant 1, which is curre
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.